Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1500 participants
OBSERVATIONAL
2022-10-25
2027-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational Study
NCT06093022
Gut Microbiota and Metabolite Signatures Associated With Lymph Node Metastasis in Pancreatic Cancer
NCT07161921
Intratumoral CD3+ and NKp46+ Cells in Colorectal Liver Metastases
NCT02615665
Cremona Population-Based Gastric Tumors Registry
NCT01662739
Immunophenotyping of Metastases From Colorectal Cancer
NCT03604926
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort observational
Overall study cohort
Cohort observational
Cohort observational
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cohort observational
Cohort observational
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* New diagnosis of the following cancers: head and neck, oesophagus/stomach, colorectal, hepato-biliary, pancreatic, lung, prostate, other urogenital, breast, gynaecological and, soft tissue sarcomas and melanomas; patients with a new diagnosis of metastatic disease will be also included;
* Eligible for active treatment;
* Written informed consent to participate in the study.
Exclusion Criteria
* Impossibility to guarantee the attendance of the follow-up visits.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituto Di Ricerche Farmacologiche Mario Negri
OTHER
Fondazione IRCCS Policlinico San Matteo di Pavia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Istituto Tumori Giovanni Paolo II,
Bari, BA, Italy
IRCCS Saverio De Bellis
Castellana Grotte, BA, Italy
Istituto Ortopedico Rizzoli
Bologna, BO, Italy
Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" IRCCS
Meldola, FC, Italy
IRCCS Ospedale Policlinico San Martino
Genova, GE, Italy
IRCCS Ospedale San Raffaele, Milano
Milan, MI, Italy
Centro di Riferimento Oncologico
Aviano, PN, Italy
IOV Istituto Oncologico Veneto
Padua, PV, Italy
AUSL IRCCS Reggio-Emilia
Reggio Emilia, RE, Italy
IDI IRCCS - Istituto Dermopatico dell'Immacolata
Roma, RM, Italy
Istituto Nazionale Tumori Regina Elena
Roma, RM, Italy
Policlinico Universitario Agostino Gemelli
Roma, RM, Italy
Istituto di Candiolo - Fondazione del Piemonte per l'Oncologia - IRCCS
Candiolo, TO, Italy
IRCCS Sacro Cuore Don Calabria
Negrar, VR, Italy
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
Napoli, , Italy
Fondazione IRCCS Policlinico San Matteo, Pavia
Pavia, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Antonella Daniele
Role: primary
Giovanni de Pergola
Role: primary
Rosalisa Cici
Role: backup
Alessandra Longhi
Role: primary
Toni Ibrahim
Role: backup
Patrizia Serra
Role: primary
Samir Guseppe Sukkar
Role: primary
Roberto Mele
Role: primary
Renato Cannizzaro
Role: primary
Maria Teresa Nardi
Role: primary
Marco Tonello
Role: backup
Debora Pezzuolo
Role: primary
Cristina Fortes
Role: primary
Lupe Sanchez Mete
Role: primary
Carmelo Pozzo
Role: primary
Maria Cristina Mele
Role: backup
Filippo Montemurro
Role: primary
Valentina Casalone
Role: backup
Stefania Gori
Role: primary
Vincenzo Quagliariello
Role: primary
Riccardo Caccialanza
Role: primary
Paolo Pedrazzoli
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Caccialanza R, De Lorenzo F, Gianotti L, Zagonel V, Gavazzi C, Farina G, Cotogni P, Cinieri S, Cereda E, Marchetti P, Nardi M, Iannelli E, Santangelo C, Traclo F, Pinto C, Pedrazzoli P. Nutritional support for cancer patients: still a neglected right? Support Care Cancer. 2017 Oct;25(10):3001-3004. doi: 10.1007/s00520-017-3826-1. Epub 2017 Jul 14. No abstract available.
Caccialanza R, Goldwasser F, Marschal O, Ottery F, Schiefke I, Tilleul P, Zalcman G, Pedrazzoli P. Unmet needs in clinical nutrition in oncology: a multinational analysis of real-world evidence. Ther Adv Med Oncol. 2020 Feb 14;12:1758835919899852. doi: 10.1177/1758835919899852. eCollection 2020.
Pedrazzoli P, Caccialanza R, Cotogni P, Degli Esposti L, Perrone V, Sangiorgi D, Di Costanzo F, Gavazzi C, Santoro A, Pinto C. The Advantages of Clinical Nutrition Use in Oncologic Patients in Italy: Real World Insights. Healthcare (Basel). 2020 May 6;8(2):125. doi: 10.3390/healthcare8020125.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRMO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.